Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suggested Biomarkers for Major Depressive Disorder
Yunus Hacımusalar, Ertuğrul Eşel
Nöro Psikiyatri Arşivi (2017)
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Improving Diagnosis of Depression With XGBOOST Machine Learning Model and a Large Biomarkers Dutch Dataset (n = 11,081)
Amita Sharma, Willem J. M. I. Verbeke
Frontiers in Big Data (2020) Vol. 3
Open Access | Times Cited: 102
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 92
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis
Yachen Shi, Di Luan, Ruize Song, et al.
European Neuropsychopharmacology (2020) Vol. 41, pp. 40-51
Closed Access | Times Cited: 76
Animal models for the study of depressive disorder
Juhyun Song, Young‐Kook Kim
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 6, pp. 633-642
Open Access | Times Cited: 61
Inflammatory Process and Immune System in Major Depressive Disorder
Norma Angélica Labra Ruiz, S S Daniel, Norma Osnaya Brizuela, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 46-53
Open Access | Times Cited: 57
Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects
Jesper Pilmeyer, Willem Huijbers, Rolf Lamerichs, et al.
Journal of Neuroimaging (2022) Vol. 32, Iss. 4, pp. 582-595
Open Access | Times Cited: 41
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 29
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 9
A systematic review of the association between biological markers and environmental stress risk factors for adolescent depression
Zuzanna Zajkowska, Annabel Walsh, Valentina Zonca, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 163-175
Open Access | Times Cited: 54
Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
Ferenc Zádor, Sâmia R.L. Joca, Gábor Nagy-Grócz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5903-5903
Open Access | Times Cited: 45
P300 parameters in major depressive disorder: A systematic review and meta-analysis
Mehmet Kemal Arıkan, Reyhan İlhan, Özden Orhan, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 4, pp. 255-266
Closed Access | Times Cited: 8
Botulinum Toxin Injections for Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape
Ilya Demchenko, Alyssa Swiderski, Helen Liu, et al.
Toxins (2024) Vol. 16, Iss. 4, pp. 191-191
Open Access | Times Cited: 7
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
The Role of Biomarkers in Psychiatry
Madia Lozupone, Maddalena La Montagna, Francesca D’Urso, et al.
Advances in experimental medicine and biology (2019), pp. 135-162
Closed Access | Times Cited: 46
Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach
Milaine Roet, Jackson Boonstra, Erdi Şahin, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2729-2729
Open Access | Times Cited: 44
Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study
Smaranika Rahman, Amena Alam Shanta, Sohel Daria, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0264404-e0264404
Open Access | Times Cited: 23
Depression and Eye Disease—A Narrative Review of Common Underlying Pathophysiological Mechanisms and their Potential Applications
Wymann Shao Wen Tang, Nicole Xer Min Lau, Muthuramalingam Naveen Krishnan, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3081-3081
Open Access | Times Cited: 5
Serum interferon-gamma level is associated with drug-naïve major depressive disorder
Sohel Daria, Maliha Afrin Proma, Mohammad Shahriar, et al.
SAGE Open Medicine (2020) Vol. 8
Open Access | Times Cited: 38
Auditory event-related potentials in separating patients with depressive disorders and non-depressed controls: A narrative review
Elina S. Kangas, Elisa Vuoriainen, Sari Lindeman, et al.
International Journal of Psychophysiology (2022) Vol. 179, pp. 119-142
Open Access | Times Cited: 21
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
Mst. Sarmin Akter, Faisal Abdullah Emon, Zabun Nahar, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis
Areeya Suktas, Tipaya Ekalaksananan, Sirinart Aromseree, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Chronic mild stress leads to aberrant glucose energy metabolism in depressed Macaca fascicularis models
Yinhua Qin, Xiaofeng Jiang, Wei Li, et al.
Psychoneuroendocrinology (2019) Vol. 107, pp. 59-69
Closed Access | Times Cited: 31
Uncaria rhynchophylla ameliorates unpredictable chronic mild stress-induced depression in mice via activating 5-HT1A receptor: Insights from transcriptomics
Yanling Qiao, Junjun Zhou, Jiahao Liang, et al.
Phytomedicine (2020) Vol. 81, pp. 153436-153436
Closed Access | Times Cited: 28
Prenatal ambient air pollution and maternal depression at 12 months postpartum in the MADRES pregnancy cohort
Theresa M. Bastain, Thomas Chavez, Rima Habre, et al.
Environmental Health (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top